Iwama E, Sakai K, Harada T, Kanda S, et al. Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations. Lung Cancer 2025;208:108756.
PMID: 40974872